Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- ChecktodayChange DetectedA new study-record version dated 2026-10-07 was added, documenting updates to the study status and contacts/locations. The history also reflects the preceding versions dated 2026-10-03 and 2026-10-06.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new version 262 dated 2026-09-22 adds the Contacts/Locations and Study Status sections to the study record history; the version dated 2026-09-18 was removed.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision (v3.7.0) is added to the record history, introducing entries for Find contact information, Contacts/Locations, and Study Status, dated 2026-09-15 to 2026-09-18, while an older revision (v3.6.6) is removed.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page history shows a new revision entry (v3.6.6) with added sections for Contacts/Locations and Study Status, and the preceding revision (v3.6.5) was removed. This reflects an update to the history-tracking UI and versioning metadata rather than substantive study data changes.SummaryDifference0.1%

- Check49 days agoChange DetectedRecent history entries document updated Study Status and Contacts/Locations for August 2026 (versions 256–258), with an older August 13 entry removed.SummaryDifference0.2%

- Check56 days agoChange DetectedNew history entries were added for versions 254 (2026-08-07) and 255 (2026-08-12), and the 2026-08-13 update adds the Study Status and Contacts/Locations sections to the record history; an earlier entry from 2026-08-05 was removed.SummaryDifference0.1%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.